Hisamitsu Pharmaceutical Co Inc (HTSUF)
24.56
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Hisamitsu Pharmaceutical Gross Profit Margin (Quarterly): 52.39% for Feb. 29, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 52.39% |
| November 30, 2023 | 55.66% |
| August 31, 2023 | 57.13% |
| May 31, 2023 | 58.32% |
| February 28, 2023 | 54.65% |
| November 30, 2022 | 56.78% |
| August 31, 2022 | 59.34% |
| May 31, 2022 | 55.87% |
| February 28, 2022 | 54.54% |
| November 30, 2021 | 58.16% |
| August 31, 2021 | 61.16% |
| May 31, 2021 | 59.79% |
| February 28, 2021 | 54.91% |
| November 30, 2020 | 62.11% |
| August 31, 2020 | 64.68% |
| May 31, 2020 | 61.13% |
| February 29, 2020 | 55.07% |
| November 30, 2019 | 67.31% |
| August 31, 2019 | 64.91% |
| May 31, 2019 | 62.71% |
| February 28, 2019 | 59.45% |
| November 30, 2018 | 63.71% |
| August 31, 2018 | 65.09% |
| May 31, 2018 | 59.41% |
| February 28, 2018 | 60.37% |
| Date | Value |
|---|---|
| November 30, 2017 | 64.86% |
| August 31, 2017 | 63.67% |
| May 31, 2017 | 61.19% |
| February 28, 2017 | 60.28% |
| November 30, 2016 | 64.33% |
| August 31, 2016 | 65.13% |
| May 31, 2016 | 64.51% |
| February 29, 2016 | 59.85% |
| November 30, 2015 | 66.97% |
| August 31, 2015 | 65.48% |
| May 31, 2015 | 63.43% |
| February 28, 2015 | 61.46% |
| November 30, 2014 | 65.55% |
| August 31, 2014 | 64.45% |
| May 31, 2014 | 63.10% |
| February 28, 2014 | 59.56% |
| November 30, 2013 | 65.31% |
| August 31, 2013 | 64.83% |
| May 31, 2013 | 62.66% |
| February 28, 2013 | 62.44% |
| November 30, 2012 | 65.15% |
| August 31, 2012 | 63.82% |
| May 31, 2012 | 63.85% |
| February 29, 2012 | 64.15% |
| November 30, 2011 | 66.66% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
52.39%
Minimum
Feb 2024
67.31%
Maximum
Nov 2019
58.63%
Average
58.16%
Median
Nov 2021
Gross Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 63.60% |
| Nxera Pharma Co Ltd | 74.17% |
| PeptiDream Inc | 35.00% |
| Healios KK | -- |
| AnGes Inc | 63.05% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 5.30% |
| Return on Assets | 4.30% |
| Return on Invested Capital | 5.27% |
| Profit Margin (Quarterly) | 4.78% |
| Operating Margin (Quarterly) | 2.31% |
| Return on Net Operating Assets | 12.55% |